release 14 software analysis Search Results


90
MBF Bioscience image analysis software neurolucida® 9.14.5 32 bit
Image Analysis Software Neurolucida® 9.14.5 32 Bit, supplied by MBF Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/image+analysis+software+neurolucida++9+14+5+32+bit/pmc06151128-51-12-19
Average 90 stars, based on 1 article reviews
image analysis software neurolucida® 9.14.5 32 bit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc commercial finite-elements analysis (fea) code ansys 19.1
Commercial Finite Elements Analysis (Fea) Code Ansys 19.1, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/commercial+finite+element+analysis++fea++software+release+17+1/pmc09248894-74-12-16
Average 90 stars, based on 1 article reviews
commercial finite-elements analysis (fea) code ansys 19.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Swanson Analysis Systems ansys workbench 14.0 fea software
Ansys Workbench 14.0 Fea Software, supplied by Swanson Analysis Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/ansys+workbench+14+0+fea+software/pm31166395-49-6-10
Average 90 stars, based on 1 article reviews
ansys workbench 14.0 fea software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc 3d finite element analysis ansys software release 18.1
3d Finite Element Analysis Ansys Software Release 18.1, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/3d+finite+element+analysis+ansys+software+release+18+1/pmc08819261-59-12-15
Average 90 stars, based on 1 article reviews
3d finite element analysis ansys software release 18.1 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Vutara Inc srx localization and visualization software v6.2
Srx Localization And Visualization Software V6.2, supplied by Vutara Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/srx+v+6+04+14+analysis+software/pmc07399380-80-6-6
Average 90 stars, based on 1 article reviews
srx localization and visualization software v6.2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
MBF Bioscience stereological image analysis software neurolucida® 9.14.5 32 bit
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Stereological Image Analysis Software Neurolucida® 9.14.5 32 Bit, supplied by MBF Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/stereological+image+analysis+software+neurolucida++9+14+5+32+bit/pmc06151128-62-5-18
Average 90 stars, based on 1 article reviews
stereological image analysis software neurolucida® 9.14.5 32 bit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Infrared Cameras Inc specialized imaging analysis software ir flash medical version 2.14.14.4
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Specialized Imaging Analysis Software Ir Flash Medical Version 2.14.14.4, supplied by Infrared Cameras Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/specialized+imaging+analysis+software+ir+flash+medical+version+2+14+14+4/pmc04555279-58-20-29
Average 90 stars, based on 1 article reviews
specialized imaging analysis software ir flash medical version 2.14.14.4 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc thermal fluid analysis software fluent 14.0
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Thermal Fluid Analysis Software Fluent 14.0, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/commercial+thermal+fluid+analysis+software+fluent+14+0/10__1299_slash_jbse__14___00265-63-1-7
Average 90 stars, based on 1 article reviews
thermal fluid analysis software fluent 14.0 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc finite element analysis software 14.5
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Finite Element Analysis Software 14.5, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/finite+element+analysis+software+14+5/10__1088_slash_1755___1315_slash_170_slash_4_slash_042087-19-1-0
Average 90 stars, based on 1 article reviews
finite element analysis software 14.5 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Swanson Analysis Systems ansys workbench 14.0 software
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Ansys Workbench 14.0 Software, supplied by Swanson Analysis Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/ansys+workbench+14+0+software/pmc08630963-42-8-11
Average 90 stars, based on 1 article reviews
ansys workbench 14.0 software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc thermal flow analysis software fluent 14.5
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Thermal Flow Analysis Software Fluent 14.5, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/thermal+flow+analysis+software+fluent+14+5/10__1299_slash_jbse__17___00597-104-0-6
Average 90 stars, based on 1 article reviews
thermal flow analysis software fluent 14.5 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
ANSYS inc finite element analysis software preprocessor ansys rel 14.5 fem software
a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by <t>image</t> <t>analysis</t> <t>software</t> (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).
Finite Element Analysis Software Preprocessor Ansys Rel 14.5 Fem Software, supplied by ANSYS inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+14+software+analysis/finite+element+analysis+software+preprocessor+ansys+rel+14+5+fem+software/pmc06161515-3-15-20
Average 90 stars, based on 1 article reviews
finite element analysis software preprocessor ansys rel 14.5 fem software - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by image analysis software (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).

Journal: Nature

Article Title: Required growth facilitators propel axon regeneration across complete spinal cord injury

doi: 10.1038/s41586-018-0467-6

Figure Lengend Snippet: a, Schematics show demarcation of SCI lesion center (Cn) and evenly spaced lines beyond the Cn placed by image analysis software (Neurolucida®, Microbrightfield) for quantification of axon intercepts in horizontal tissue sections of mice with SCI and one (D 1 ) or two (D 1 +D 2 ) hydrogel depots. b, Multi-fluorescent, survey images show BDA-labeled axons and GFAP-labelled astrocytes that demarcate astrocyte scar proximal borders (PB) and distal borders (DB) around the non-neural lesion core (LC) after SCI. The hydrogel of the empty depot (left) was tagged with a blue fluorescent label for visualization. Note the essential absence of axons passing the astrocyte scar (AS) proximal border (PB) to reach the lesion center (Cn) or beyond in the mouse with SCI plus empty depot (left), in striking contrast with the large number of axons that regrew through the lesion core (LC) and passed beyond the distal astrocyte scar border (DB) into spared grey matter (gm) in the mouse with full treatment of stimulatory AAV plus growth factors (right). GFAP staining shows that the SCI lesions are anatomically complete across the entire width of the spinal cord in both cases. Note that the second depot was placed at 9 days after SCI, by which time the distal astrocyte scar border was essentially formed . Note also that astrocytes do not migrate into the depots, potentially giving the mistaken impression of cavity formation when looking only at the GFAP channel alone. Nevertheless, examination of other fluorescence channels shows that depot sites clearly contain DAPI-stained stromal cells and BDA-positive axons. c, Large area survey images of BDA-labeled axons in composite mosaic scans of horizontal sections. In a control mouse (top) that received SCI plus empty depot, few axons reach the lesion center, almost none pass beyond, and no axons are present at 3mm. In the a treated mouse (middle) that received stimulatory AAV plus growth factors, many axons regrow through the lesion core and reach or pass 1.5mm beyond the lesion center, which is the equivalent length of a full thoracic spinal segment in mice . Note also that there are no axons present at 3mm, demonstrating that the SCI lesion was complete and that axons that are found past the lesion center represent axon regrowth after SCI in response to the experimental manipulations. In an uninjured mice (bottom), there are many labeled axons at the distance equivalent to 3mm beyond the location of SCI in injured mice. d, Graph shows mean±SEM numbers of axon intercepts at lesion centers for all experimental groups (dots in graphs show numbers and distribution of individual mice per group). (ns not significant versus SCI-only, # P <0.01 versus SCI-only and ns versus each other, ** P <0.01, *** P <0.001 versus all other groups, one-way ANOVA/Bonferroni, F (12, 57) = 22.3).

Article Snippet: Cell counts were performed using stereological image analysis software (StereoInvestigator®, 9.14.5 32 Bit, and NeuroLucida®, 9.14.5 32 Bit, MicroBrightField, Williston, VT) operating a computer-driven microscope regulated in the x, y and z axes (Zeiss).

Techniques: Software, Labeling, Staining, Fluorescence, Control